Suppr超能文献

BNP 与 NT-proBNP 在儿科人群中的比较。

Comparison between BNP and NT-proBNP in pediatric populations.

机构信息

Department of Pathology & Immunology. Washington University School of Medicine, St. Louis, MO, USA.

Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA.

出版信息

Clin Biochem. 2022 Nov-Dec;109-110:74-78. doi: 10.1016/j.clinbiochem.2022.08.003. Epub 2022 Aug 5.

Abstract

BACKGROUND

B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are essential biomarkers for the evaluation of cardiac pathologies. However, pediatric reference intervals for BNP and NT-proBNP are not well defined and concordance between them in the evaluation of pediatric patients has been poorly described.

METHODS

Paired BNP and NT-proBNP testing was performed on 311 specimens representing 175 pediatric patients. Pediatric BNP and NT-proBNP reference intervals derived from the literature were used to evaluate concordance of results based on age group and cardiac pathology.

RESULTS

Deming regression analysis of BNP and NT-proBNP results revealed a slope of 13.63 (95% CI, 10.35-16.92) and y-intercept of -977.8 (-2063-107.2) with a positive Spearman correlation (r = 0.91). By age group, concordance kappa between BNP and NT-proBNP was 1.0 for 0-10 days, 0.23 (0-0.62) for 11-30 days, 0.82 (0.67-0.97) for 31 days-1 year, 0.81 (0.57-1.0) for 1-2 years and 0.73 (0.64-0.86) for 2-18 years. The ratio of NT-proBNP to BNP was lowest in heart transplant patients (ratio, 6.5 [95% CI, 5.1-8.1]) relative to those with heart disease (10.5 [8.8-13.7]) and pulmonary hypertension (14.2 [11.3-16.0]) but no differences in concordance were observed. For serial specimens, 21% displayed inverse, discordant changes in BNP and NT-proBNP results. Review of discordant serial results revealed that kinetics of changes was comparable and unlikely to be clinically significant.

CONCLUSIONS

There is positive correlation and moderate concordance between BNP and NT-proBNP in the pediatric population studied.

摘要

背景

B 型利钠肽(BNP)和氨基末端 B 型利钠肽前体(NT-proBNP)是评估心脏病理的重要生物标志物。然而,儿科 BNP 和 NT-proBNP 的参考区间尚未明确,并且它们在儿科患者评估中的一致性也描述得很差。

方法

对 311 份代表 175 名儿科患者的标本进行了 BNP 和 NT-proBNP 的配对检测。使用文献中得出的儿科 BNP 和 NT-proBNP 参考区间,根据年龄组和心脏病理评估结果的一致性。

结果

BNP 和 NT-proBNP 结果的 Deming 回归分析显示斜率为 13.63(95%CI,10.35-16.92),截距为-977.8(-2063-107.2),具有正 Spearman 相关关系(r=0.91)。按年龄组划分,BNP 和 NT-proBNP 之间的一致性 Kappa 为 0-10 天为 1.0,11-30 天为 0.23(0-0.62),31 天-1 岁为 0.82(0.67-0.97),1-2 岁为 0.81(0.57-1.0),2-18 岁为 0.73(0.64-0.86)。与心脏病(比值 10.5 [8.8-13.7])和肺动脉高压(比值 14.2 [11.3-16.0])患者相比,心脏移植患者的 NT-proBNP 与 BNP 的比值最低(比值 6.5 [95%CI,5.1-8.1]),但一致性无差异。对于连续标本,21%的标本 BNP 和 NT-proBNP 结果呈反向、不一致变化。对不一致的连续结果进行审查发现,变化的动力学是可比的,不太可能具有临床意义。

结论

在研究的儿科人群中,BNP 和 NT-proBNP 之间存在正相关和中度一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验